Poster: Drug/Disease Modelling - Other Topics

Implications of the changes in the pharmacokinetics of raltegravir in pregnant and post-partum women undergoing antiretroviral therapy against HIV infection.

Thursday 16 October, 2025

Objectives: While integrase inhibitors have become first line antiretroviral therapy for non-pregnant adults [1], there have been few studies supporting…

Read more

Population pharmacokinetics of cobicistat in once and twice daily regimens in various populations

Thursday 16 October, 2025

Objectives: Cobicistat (COBI) is a selective, mechanism-based inhibitor of the cytochrome P450 (CYP) 3A-enzyme.(1) COBI is approved for pharmacokinetic (PK)…

Read more

Comparison of oxazolidinones’ exposure-response for the treatment of tuberculosis

Thursday 16 October, 2025

Objectives: Tuberculosis (TB) is one of the world’s deadliest infectious diseases, causing 1.3 million deaths in 2022. Treatment success rates are…

Read more

Dose rationale and metrics of target exposure for tacrolimus and mycophenolate in paediatric patients undergoing solid organ transplantation

Thursday 16 October, 2025

Introduction: Tacrolimus (TAC) is an immunosuppressant prescribed often in combination with mycophenolic acid to patients who undergo organ transplantation. TAC exerts…

Read more

Leveraging in vitro data from novel drug candidates to prioritize antibody combinations in autoimmune disease using a QSP model of IBD

Thursday 16 October, 2025

Objectives: For many autoimmune indications the treatment response has reached a ceiling effect and so novel combination treatment approaches may…

Read more

Towards an integrated mPBPK/PD model for drug-optimization and prediction of relapse after treatment of tuberculosis in mice

Thursday 16 October, 2025

Objectives: The treatment of tuberculosis (TB), one of the most harmful infectious diseases killing millions of people worldwide [1], still…

Read more

In-silico clinical trials in virtual asthma patients powered by QSP accelerated the development of lunsekimig

Thursday 16 October, 2025

Introduction: Asthma is a heterogenous disease that affects millions of people worldwide. Despite the availability of multiple treatment options, a significant…

Read more

Population pharmacokinetic modelling of whole blood and intracellular tacrolimus in adult kidney transplanted patients

Thursday 16 October, 2025

Introduction: Tacrolimus is an immunosuppressive drug used to prevent organ rejection in kidney transplanted patients. It has a narrow therapeutic…

Read more

Sevoflurane Pharmacokinetics and Pharmacodynamics in Adults During General Anaesthesia

Thursday 16 October, 2025

Background Sevoflurane vapour is inhaled for the induction and maintenance of general anaesthesia. Sevoflurane vapour concentration is measured in real-time…

Read more

Population pharmacokinetic Models of regular SC insulin for hyperglycemia following acute ischemic stroke among patients with and without pre-existing diabetes mellitus

Thursday 16 October, 2025

Introduction/Objectives: Regardless of pre-stroke diabetes status, patients admitted to the hospital for acute ischemic stroke (AIS) are frequently observed to…

Read more